Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1987 3
1988 1
1989 1
1990 32
1991 3
1993 1
1995 1
1996 1
1997 1
2000 3
2002 1
2008 2
2011 2
2012 1
2014 2
2016 1
2017 3
2018 1
2019 5
2020 3
2021 1
2022 1
2023 2
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
An unnatural biopolymer.
Cho CY, Moran EJ, Cherry SR, Stephans JC, Fodor SP, Adams CL, Sundaram A, Jacobs JW, Schultz PG. Cho CY, et al. Among authors: moran ej. Science. 1993 Sep 3;261(5126):1303-5. doi: 10.1126/science.7689747. Science. 1993. PMID: 7689747
Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease.
Donohue JF, Kerwin E, Sethi S, Haumann B, Pendyala S, Dean L, Barnes CN, Moran EJ, Crater G. Donohue JF, et al. Among authors: moran ej. Respir Med. 2019 Jul;153:38-43. doi: 10.1016/j.rmed.2019.05.010. Epub 2019 May 23. Respir Med. 2019. PMID: 31150963 Free article. Clinical Trial.
A multivalent approach to drug discovery for novel antibiotics.
Long DD, Aggen JB, Christensen BG, Judice JK, Hegde SS, Kaniga K, Krause KM, Linsell MS, Moran EJ, Pace JL. Long DD, et al. Among authors: moran ej. J Antibiot (Tokyo). 2008 Oct;61(10):595-602. doi: 10.1038/ja.2008.79. J Antibiot (Tokyo). 2008. PMID: 19168973
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
Belperio J, Nguyen T, Lombardi DA, Bogus M, Moskalenko V, Singh D, Haumann B, Bourdet DL, Kaufman E, Pfeifer ND, Thompson CG, Woo J, Moran EJ, Saggar R. Belperio J, et al. Among authors: moran ej. BMJ Open Respir Res. 2023 Jul;10(1):e001627. doi: 10.1136/bmjresp-2023-001627. BMJ Open Respir Res. 2023. PMID: 37460276 Free PMC article. Clinical Trial.
Wastewater surveillance provides 10-days forecasting of COVID-19 hospitalizations superior to cases and test positivity: A prediction study.
Hill DT, Alazawi MA, Moran EJ, Bennett LJ, Bradley I, Collins MB, Gobler CJ, Green H, Insaf TZ, Kmush B, Neigel D, Raymond S, Wang M, Ye Y, Larsen DA. Hill DT, et al. Among authors: moran ej. Infect Dis Model. 2023 Oct 31;8(4):1138-1150. doi: 10.1016/j.idm.2023.10.004. eCollection 2023 Dec. Infect Dis Model. 2023. PMID: 38023490 Free PMC article.
75 results